leisure time -WSS

leisure time

author：explore 2025-08-06 04:47:33 - browse：71

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： NEJM study link tiny plastics in blood vessels to heart problems

hotspot

explore

WSS

Just how do doctors, lawmakers, and the public define abortion?

A deep dive into Applied Therapeutics’ data, and questions on Cassava

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

The drug industry has found itself all alone in Washington

New case study details death in closely watched Alzhiemer's trial

First medicine developed to treat MASH expected to be approved soon

knowledge

leisure time

leisure time

How one medical school became remarkably diverse

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Psychedelics group wrestles with new pharma identity

4th of July breaks record for highest global temperature ever measured

Medicare details structure of new drug price negotiation program

New case study details death in closely watched Alzhiemer's trial

George Santos makes 1st court appearance after pleading not guilty to 13 counts

NEJM study link tiny plastics in blood vessels to heart problems

focus

First medicine developed to treat MASH expected to be approved soon

Change Healthcare payments predicted restored March 15

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Pfizer's Covid pill remains 89% effective in final analysis, company says

Air quality improving but still lags in Black, Hispanic communities

Van's Gluten Free Original Waffles recalled for possible wheat allergen

hotspot

explore

knowledge

focus